Raut et al developed two nomograms for patients with a retroperitoneal sarcoma. One of these nomograms predicts disease-free survival. The authors are from multiple institutions in the North America and Europe.
Patient selection: retroperitoneal sarcoma
Outcome: 7-year disease-free survival (DFS)
Parameters:
(1) tumor diameter in centimeters
(2) FNCLCC grade
(3) histologic subtype
(4) multifocality
Tumor Diameter |
Points |
0 to 20 cm |
|
20 to 30 cm |
(0.4704 * (size)) + 35.868 |
30 to 80 cm |
53.821 - (0.1218 * (size)) |
Parameter |
Finding |
Points |
FNCLCC grade |
Grade 1 |
0 |
|
Grade 2 |
61.7 |
|
Grade 3 |
100 |
histologic subtype |
solitary fibrous tumor |
0 |
|
malignant peripheral nerve sheath tumor |
0.1 |
|
liposarcoma, dedifferentiated |
28 |
|
leiomyosarcoma |
40 |
|
liposarcoma, well-differentiated |
50 |
|
unclassified, undifferentiated pleomorphic |
42 |
|
other |
31 |
multifocal |
no (unifocal) |
0 |
|
yes |
46.6 |
total score =
= SUM(points for all 4 parameters)
Interpretation:
• minimum score: 0
• maximum score: 246.6
Total Score |
7-year disease-free survival |
< 4.7 |
> 95% |
4.7 to 212 |
see X below |
> 212 |
< 1% |
X =
= (-0.00000094416 * ((score)^3)) + (0.00019188 * ((score)^2)) - (0.034428 * (score)) + 3.1601
probability =
= 1 / (1 + EXP((-1) * X))
Specialty: Hematology Oncology